Gabriel Schwartz, MSN, NP, explains how mechanisms of action determine the safety of systemic treatments in metastatic colorectal cancer post chemotherapy.
Systemic Treatment of mCRC Post Standard Chemotherapy
Advertisement
Advertisement
Trending on Oncology Nursing News
1
National Cancer Institute Explores Ivermectin as a Potential Cancer Therapy
2
Nurses Advised: ASCO Cautions Against Ivermectin and Fenbendazole Use
3
Daraxonrasib Nearly Doubles Survival in Pancreatic Cancer: What Nurses Need to Know
4
'Somebody That Feels Like a Friend': Teddi Mellencamp Honors Oncology Nurses
5